Cosmos Pharmaceutical reports strong results, raises dividends

Cosmos Pharmaceutical Corporation reported a 4.8% increase in net sales to 1,011,390 million yen for the fiscal year ended May 31, 2025, with operating profit surging 28.3% to 40,404 million yen. Profit attributable to owners grew 26.7% to 30,978 million yen.

The company declared an annual dividend of 70.00 yen per share for fiscal 2025, up from 60.00 yen in fiscal 2024, and forecasts 75.00 yen for fiscal 2026.